Composition and method for affecting male and female hormone levels
AssigneeNokomis Research, Inc.
InventorsRICHARD J. BENDERA, LEANNA S. WILSON
Life of this patent
Estimating the term…
Abstract
A composition and method for treating infertility and sexual dysfunction of a male or female human by balancing hormone levels of cortisol, dehydroepiandrosterone sulfate, testosterone, progesterone, and estradiol in the human. The composition comprises effective amounts of spermine and spermidine, administered at least once daily for a period of at least thirty days.
Claims20
A method for treating infertility in a human, the method comprising the steps of:
- identifying a level of at least one hormone in the human that is causing the infertility in the human, wherein the at least one hormone is selected from the group consisting of cortisol, dehydroepiandrosterone sulfate, testosterone, progesterone, and estradiol;
- administering a composition to the human that comprises between approximately 2.5 mg and 2.7 mg spermine and between approximately 2.5 mg and 2.7 mg spermidine;
- and
- modifying the level of the at least one hormone in order to treat the infertility in the human.
A method for treating infertility in a human by balancing hormone levels in the human, the method comprising the steps of:
- identifying an imbalance of at least one hormone level in the human that is causing the infertility in the human, wherein the at least one hormone is selected from the group consisting of cortisol, dehydroepiandrosterone sulfate, testosterone, progesterone, and estradiol;
- administering a composition at least once daily to the human consisting of between approximately 2.5 mg and 2.7 mg spermine and between approximately 2.5 mg and 2.7 mg spermidine for a period of at least thirty days;
- and
- modifying the level of the at least one hormone in order to treat the infertility in the human.
A method for treating hormone imbalance in a human, the method comprising the steps of:
- identifying an imbalance of at least one hormone level in the human, wherein the at least one hormone is selected from the group consisting of cortisol, dehydroepiandrosterone sulfate, testosterone, progesterone, and estradiol;
- administering a composition at least once daily to the human consisting of between approximately 2.5 mg and 2.7 mg spermine and between approximately 2.5 mg and 2.7 mg spermidine for a period of at least thirty days;
- and
- modifying the level of the at least one hormone in order to treat the hormone imbalance, wherein modifying the level of the at least one hormone further comprises at least one of:
- decreasing a cortisol level in the human;
- increasing at least one of a dehydroepiandrosterone sulfate level, an estradiol level, and a progesterone level when the human is female;
- and
- decreasing at least one of an estradiol level and a progesterone level when the human is male.
Dependencies are inferred from the claim text.